Acupuncture for Post-Traumatic Stress in Combat Veterans
1 other identifier
interventional
90
1 country
1
Brief Summary
The objective of this study is to determine if acupuncture is an effective treatment option for treating combat Veterans with PTSD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2016
CompletedFirst Posted
Study publicly available on registry
August 18, 2016
CompletedStudy Start
First participant enrolled
May 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedApril 8, 2020
April 1, 2020
3.4 years
August 8, 2016
April 6, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Clinician Administered PTSD Scale (CAPS-5) PTSD Diagnosis
4 months: Baseline CAPS to post treatment
Study Arms (2)
Verum Acupuncture
EXPERIMENTALPatients will receive verum acupuncture twice weekly for twelve weeks.
Sham Placebo Acupuncture
PLACEBO COMPARATORPatients will receive sham placebo acupuncture twice weekly for twelve weeks.
Interventions
Patients will be randomized to either treatment arm, verum acupuncture or sham placebo acupuncture.
Eligibility Criteria
You may qualify if:
- Veteran Age 18 to 55
- DSM-5 criteria for chronic PTSD on Clinical Administered PTSD Scale (CAPS-5)
- CAPS-5 score of ≥ 26 and meeting criteria for each of 4 symptoms
You may not qualify if:
- Current and past six-months psychosis
- Substance dependence within 6 months (evidence of tolerance and/or withdrawal)
- Thyroid disease
- Decisional incapacity (e.g., dementia)
- Centrally acting medications that have a potential effect on biological expression (e.g., beta-blockers, opiates, and ≥10mg equivalent of diazepam/day)
- Pain levels requiring opiate medications
- Known exposure to chemicals or physical trauma that cause neuropsychiatric sequelae
- Severe depression (Beck Depression Inventory-II score ≥30)
- A diagnosed and untreated sleep breathing disorder (SBD)
- High risk of a SBD as indicated by snoring ≥50 of nights plus one of any
- Any witnessed apnea
- Feeling non-refreshed in the morning ≥50 of mornings
- Daytime sleepiness indicated by falling asleep with routine tasks such as watching TV or reading
- Non-response to ≥2 evidence-based PTSD treatments (adequate medication of 12 weeks or completion to PE, CPT or an intensive program)
- Treatment non-adherence indicated by stopping treatment or \>3 missed appointments in the course of PTSD EBT
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Veterans Affairs Long Beach Healthcare System
Long Beach, California, 90822, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Hollifield, MD
Tibor Rubin VA Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Program for Traumatic Stress
Study Record Dates
First Submitted
August 8, 2016
First Posted
August 18, 2016
Study Start
May 19, 2018
Primary Completion
September 30, 2021
Study Completion
March 31, 2022
Last Updated
April 8, 2020
Record last verified: 2020-04